Interaction between hyperhomocysteinemia and inherited thrombophilic factors in venous thromboembolism

Seminars in Thrombosis and Hemostasis

Volumn 26, Issue 3, 2000, Pages 305-311

  De Stefano, V ^a   Casorelli, I ^a   Rossi, E ^a   Zappacosta, B ^a   Leone, G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Factor V Leiden; Hyperhomocysteinemia; Inherited thrombophilia; Prothrombin G20210A mutation; Venous thrombosis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5; HOMOCYSTEINE; PROTHROMBIN;

CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DISEASE SEVERITY; GENE MUTATION; GENETIC ASSOCIATION; HOMOCYSTINURIA; HUMAN; HYPERHOMOCYSTEINEMIA; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; THROMBOEMBOLISM; THROMBOPHILIA; VEIN THROMBOSIS;

3' UNTRANSLATED REGIONS; ACTIVATED PROTEIN C RESISTANCE; COMORBIDITY; FACTOR V; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HEAT; HUMANS; HYPERHOMOCYSTEINEMIA; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION, MISSENSE; ODDS RATIO; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POINT MUTATION; PROTEIN DENATURATION; PROTHROMBIN; RISK; RISK FACTORS; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 0033813145     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Homocysteine and thrombotic disease
2. Hyperhomocysteinemia, atherosclerosis and thrombosis
3. High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis
4. Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease
5. Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism
6. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis
7. Hyperhomocysteinemia and deep-vein thrombosis. A case-control study
8. Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism
9. Moderate hyperhomocysteinemia is a highly prevalent defect in Spanish patients with venous thromboembolic disease
10. Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis?
11. Hyperhomocysteinemia and venous thrombosis: A meta-analysis
12. The mutation Ala677Val in the methylene tetrahydrofolate reductase gene: A risk factor for arterial disease and venous thrombosis
13. The VITA project: C677T mutation in the methylene-tetrahydrofolate reductase gene and risk of venous thromboembolism
14. The C677T MTHFR variant and the risk of venous thrombosis
15. Effect of the MTHFRC677T variant on risk of venous thromboembolism: Interaction with factor V Leiden and prothrombin (F2G20210A) mutations
16. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis
17. Prevalence of the 677C to T mutation in the methylenetetrahydrofolate reductase gene in Italian patients with venous thrombotic disease
18. 20210 mutation
19. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes
20. The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: Prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels
21. 506)
22. Coexistence of hereditary homocystinuria and factor V Leiden. Effect on thrombosis
23. Thrombophilia, homocystinuria, and mutation of the factor V gene
24. Homozygous cystathionine β-synthase deficiency, combined with factor V Leiden or thermolabile methylenetetrahydrofolate reductase in the risk of venous thrombosis
25. Factor V Leiden (Arg506Gln), a confounding genetic risk factor but not mandatory for the occurrence of venous thromboembolism in homozygotes and obligate heterozygotes for cystathionine β-synthase deficiency
26. Thrombophilia, homocystinuria, and mutation of the factor V gene
27. Prevalence of mild hyperhomocysteinemia and association with thrombophilic genotypes (factor V Leiden and prothrombin G20210A) in Italian patients with venous thromboembolic disease
28. Inherited thrombophilia: Pathogenesis, clinical syndromes, and management
29. A common genetic variation in the 3'untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
30. No evidence for an increase of the risk for venous thrombosis in patients with factor V Leiden by the homozygous mutation in the methylenetetrahydrofolate reductase gene
31. Prevalence of factor V 1691G to A and methylenetetrahydrofolate reductase 677C to T mutated genes in patients with venous thrombosis
32. Additional genetic risk factors for venous thromboembolism in carriers of the factor V Leiden mutation